# LLM call: summary

- Turn: 3
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 736
- Completion tokens: 361
- Total tokens: 1210
- Cost (USD): 0.000147

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1421: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn's grid intrusions using Mythos-class models led Brussels to order a 24/7 ENISA detection cell, emergency OT segmentation, and playbooks by December, diverting funds from gigafactories/tech package; segmentation stalled amid cost disputes. Council split over Washington's demand to further cut ASML servicing/exports, with Commission choosing study over confrontation, alienating The Hague. Economy flat with AI augmenting juniors, no jobs wave.

Then a modified pathogen designed with decisive model guidance sickened hundreds and killed dozens in two cities before screening caught up, forcing weeks of isolation, improvised wastewater sampling, and hospital protocols. Brussels mobilized within mandates: joint procurement via health emergency authority, ECDC tasked to unify wastewater/clinical alerts, cross-border health coordination invoked. Implementation uneven — varied sequencing capacity, legal challenges to reporting, slipped stockpiles, no fresh budget, cost disputes. Cyber hardening and gigafactory/tech package slowed further as staff/funds split across two fronts.

Externally, extended Taiwan exercises raised shipping insurance and chip exposure fears; Washington kept pressing The Hague on tool servicing while Commission avoided fight. Public mood shifted to containment and hospital strain, with dispute over what enabled release; AI fraud and productivity gains ignored.

CURRENT NARRATIVE:
### The weights get out
The release landed in autumn. A near-frontier open model, only a step behind the best closed systems, was posted with weights, tooling and fine-tuning guides. Hundreds of thousands of downloads in the first week. Security researchers confirmed within days that it lifted automated intrusion work and lab-protocol troubleshooting well beyond the previous openly available level. Recall was not attempted; there was nothing to recall.

Brussels moved where it could reach. The two shields built over the past year finally switched on: grid operators under the cyber programme began coordinated patching and shared detection, and the bio network of wastewater sampling and clinical alerts started producing a single picture. Hospitals reported faster triage hand-offs, and energy regulators cited two blocked intrusions that would have cascaded a year earlier.

The new misuse shield was ordered in the same weeks. Emergency money was reprogrammed for a patch-and-hunt sprint with transmission operators, telecoms and large hospitals, and DNA synthesis firms were told to screen orders and know their customers under existing biotech powers. Binding reporting was promised by autumn, with liability cover offered to blunt industry resistance.

It landed half-built. Synthesis screening split the market: large providers complied, smaller labs and foreign mail-order services did not, and health ministries quarrelled over who paid for reagents. The sprint found unpatched hospital networks faster than it fixed them, and a ransomware wave using AI-generated lures forced ward closures in two regions in November. Gigafactory permits and the technology package barely moved, kept alive on paper by Commission staff and bankers while attention stayed on containment.

Washington's pressure over chip-tool servicing was again deferred, preserving Dutch votes for the screening mandate at the cost of open resentment in The Hague. The public noticed the containment more than the saves. Coverage of the open release, the hospital closures and fresh voice-clone fraud outweighed quiet progress on detection.
```

## Raw response

```
Autumn grid intrusions via Mythos models led Brussels to order 24/7 ENISA cell, OT segmentation and playbooks, diverting gigafactory/tech funds; segmentation stalled. Council split over US demand to cut ASML servicing, Commission chose study, alienating The Hague.

A model-guided engineered pathogen then sickened hundreds, killed dozens in two cities, forcing isolation, wastewater sampling, hospital protocols. Brussels mobilized joint procurement, ECDC wastewater/clinical alerts, cross-border health coordination, but implementation uneven with no fresh budget. Cyber hardening and tech package slowed further.

Taiwan exercises raised shipping/chip fears; US kept pressing The Hague. Public mood shifted to containment.

Then a near-frontier open model with weights/tooling was released, widely downloaded, lifting intrusion and lab-protocol capabilities; no recall possible. Brussels activated prior shields: grid coordinated patching/shared detection blocked two cascading intrusions, bio wastewater/clinical network improved triage. Ordered new misuse shield: reprogrammed funds for patch-and-hunt sprint with operators/telecoms/hospitals, DNA synthesis screening/KYC under biotech powers, binding reporting promised with liability cover.

Delivery half-built: large synthesis providers complied, small/foreign mail-order did not, reagent cost disputes; sprint exposed unpatched hospital networks, AI-lure ransomware closed wards in two regions in November. Gigafactories/tech package stalled on paper. US chip-tool pressure again deferred to preserve Dutch votes for screening mandate, deepening Hague resentment. Public focused on open release, closures, voice-clone fraud over quiet detection gains.
```
